ReviewJournal of human hypertension2002
Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.
Review in Journal of human hypertension, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 136 citations in OpenAlex.
- Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population.PloS one · 2013Trial
- Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.Pediatric cardiologyTrial
- The Effect of Renal Denervation on Capillary Density in Patients With Uncontrolled Hypertension.Microcirculation (New York, N.Y. : 1994) · 2025Article
- Microalbuminuria as a Prognostic Marker in Essential Hypertension.Current medicinal chemistry · 2025Review
- Association of 24-h urinary sodium excretion with microalbuminuria in a Chinese population.Scientific reports · 2023Article
- Comparing the associations of clinic vs. ambulatory blood pressure with subclinical organ damage in young healthy adults: the African-PREDICT study.Hypertension research : official journal of the Japanese Society of Hypertension · 2021Article
- Decreased Urinary Levels ofInternational journal of molecular sciences · 2020Article
- Vascular, cardiac and renal target organ damage associated to arterial hypertension: which noninvasive tools for detection?Journal of human hypertension · 2020Review
- Article
- Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women.Journal of menopausal medicine · 2016Article
- Microalbuminuria in primary hypertension: a guide to optimal patient management?Journal of nephrology · 2016Review
- Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.Journal of human hypertension · 2016Article
- Chronic kidney disease as a predictor of clinical risk in the elderly.Journal of geriatric cardiology : JGC · 2016Article
- Article
- Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio.PloS one · 2014Article
- Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study.BMC nephrology · 2013Article
- Relationship between inflammation and microalbuminuria in prehypertension.Journal of human hypertension · 2013Article
- Renal resistive index and low-grade inflammation in patients with essential hypertension.Journal of human hypertension · 2012Article
- Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients.European journal of clinical nutrition · 2012Article
- The metabolic syndrome in Africa: Current trends.Indian journal of endocrinology and metabolism · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper reviews the existing epidemiological and clinical evidence about the relationships of non-diabetic microalbuminuria with cardiovascular risk factors such as elevated blood pressure (BP), systolic particularly, cardiac hypertrophy, adverse metabolic status, smoking habits, elevated angiotensin II levels, endothelial dysfunction, acute and perhaps subclinical inflammation. Because of that unique property of reflecting the influence of so many clinically relevant parameters, microalbuminuria may legitimately be defined as an integrated marker of cardiovascular risk, an unique profile among the several prognostic predictors available to stratify risk in hypertensive patients. Recent cohort studies also showed associations with cardiovascular morbidity and mortality independently from conventional atherogenic factors. This behaviour, whose understanding still needs further elucidation, suggests to measure albuminuria and to screen patients at a higher absolute risk in whom preventive treatment is expected to be more beneficial than in those with a lower absolute risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.